Whether the FTO gene can help with blood sugar requires a nuanced answer. FTO (Fat Mass and Obesity Associated) is one of the most studied genes in relation to obesity and type 2 diabetes. Multiple GWAS have shown that certain risk variants (e.g., rs9939609) are associated with higher BMI and a modest increase in insulin resistance and fasting glucose levels. However, effect sizes are small – the variant explains only about 1–2% of BMI variation. FTO influences blood sugar indirectly through appetite regulation and energy expenditure, not directly via insulin secretion. Importantly, carrying a risk allele does not guarantee metabolic dysfunction. Lifestyle factors such as diet, exercise, and sleep have a far greater impact on blood glucose than FTO genetics. Consumer DNA tests tend to overstate clinical relevance. A standalone FTO analysis is not useful for blood sugar management; it may be considered only as part of a polygenic risk score. Evidence: human-moderate (GWAS).
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-06e41c36681924f75349588f